UCLA Researchers Develop Molecule That Restores Memory in Alzheimer's Model Mice
The new compound, DDL-920, shows potential to rejuvenate cognitive functions by enhancing brain's gamma oscillations.
- DDL-920, developed by UCLA Health, revives memory circuits in Alzheimer's-afflicted mice.
- Unlike existing drugs, DDL-920 improves cognition without targeting amyloid plaques.
- The molecule enhances gamma oscillations, crucial for cognitive processes and working memory.
- Initial trials show treated mice perform on par with healthy mice in memory tests.
- Further research is needed to determine safety and efficacy in humans.